Travere Therapeutics
TVTX
$5.46
Share price
3.80%
Change (1 day)
-75.85%
Change (1 year)
Categories
P/S ratio for Travere Therapeutics (TVTX)
P/S ratio as of April 2024 (TTM): 2.09
According to Travere Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.08985. At the end of 2023 the company had a P/S ratio of 3.40.
P/S ratio history for Travere Therapeutics from 2011 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.40 | -53.03% |
| 2022 | 7.23 | -13.42% |
| 2021 | 8.35 | 16.34% |
| 2020 | 7.18 | 105.76% |
| 2019 | 3.49 | -38.81% |
| 2018 | 5.70 | 6.69% |
| 2017 | 5.35 | -0.03% |
| 2016 | 5.35 | -24.07% |
| 2015 | 7.04 | -37.71% |
| 2014 | 11.3 | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.00 | -52.11% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 4,326.09% | 🇺🇸 USA |